首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Sonal V.Bhujbal1,Biplob Mitra2,Uday Jain3,Yuchuan Gong2,Anjali Agrawal2,Shyam Karki2,Lynne S.Taylor1,Sumit Kumar2,Qi(Tony) Zhou1(Department of Industrial and Physical Pharmacy,College of Pharmacy,Purdue University;Oral Product Development,Bristol Myers Squibb;Material Science and Engineering,Bristol Myers Squibb).Pharmaceutical amorphous solid dispersion:A review of manufacturing strategies[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yilin Zheng1,Jinxiang Ye2,Ziying Li1,Haijun Chen2,Yu Gao1,2(Cancer Metastasis Alert and Prevention Center,College of Chemistry,Fuzhou University;Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy,Fuzhou University).Recent progress in sono-photodynamic cancer therapy:From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Ting Liu1,Minglong Chen1,Jintao Fu1,Ying Sun1,Chao Lu2,Guilan Quan2,Xin Pan1,Chuanbin Wu2(School of Pharmaceutical Sciences,Sun Yat-sen University;College of Pharmacy,Jinan University).Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Mingming Zhang,Shan Gao,Dongjuan Yang,Yan Fang,Xiaojie Lin,Xuechao Jin,Yuli Liu,Xiu Liu,Kexin Su,Kai Shi(Department of Pharmaceutics,School of Pharmacy,Shenyang Pharmaceutical University).Influencing factors and strategies of enhancing nanoparticles into tumors in vivo[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Matthew Behr1,Jing Zhou2,Bing Xu3,Hongwei Zhang1(Department of Pharmaceutical Sciences,School of Pharmacye Boston,Massachusetts College of Pharmacy and Health Sciences;Department of Endocrinology,Tangshan Hospital of Traditional Chinese Medicine;Department of Chemistry,Brandeis University).In vivo delivery of CRISPR-Cas9 therapeutics:Progress and challenges[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yanping Huang1,Qin Yu1,Zhongjian Chen1,Wei Wu1,2,Quangang Zhu1,Yi Lu1,2(Shanghai Skin Disease Hospital,Tongji University School of Medicine;Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University).In vitro and in vivo correlation for lipid-based formulations:Current status and future perspectives[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yujie Shi1,An Lu1,Xiangyu Wang1,Zakia Belhadj1,Jiancheng Wang1,2,Qiang Zhang1,2(Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems,School of Pharmaceutical Sciences,Peking University;State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University).A review of existing strategies for designing long-acting parenteral formulations:Focus on underlying mechanisms, and future perspectives[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Zichen Zhang1,Yi Lu1,Jianping Qi1,Wei Wu1,2(Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University;Center for Medical Research and Innovation,Shanghai Pudong Hospital,Fudan University Pudong Medical Center).An update on oral drug delivery via intestinal lymphatic transport[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yan Zhao1,2,Xiaolu Li2,Wenbo Zhang2,Lanlan Yu2,Yang Wang2,Zhun Deng2,Mingwei Liu2,Shanshan Mo2,Ruonan Wang2,Jinming Zhao1,Shuli Liu3,Yun Hao1,Xiangdong Wang1,Tianjiao Ji4,5,Luo Zhang1,6,Chenxuan Wang2(Department of Otolaryngology Head and Neck Surgery,Beijing Tongren Hospital,Capital Medical University and Beijing Key Laboratory of Nasal Diseases,Beijing Institute of Otolaryngology;State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Clinical Laboratory,Peking University Civil Aviation School of Clinical Medicine;CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology;Center of Materials Science and Optoelectronics Engineering,University of Chinese Academy of Sciences;Chinese Academy of Medical Sciences and Peking Union Medical College).Trends in the biological functions and medical applications of extracellular vesicles and analogues[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Xiaochun Wang1,Imran Shair Mohammad2,Lifang Fan3,Zongmin Zhao4,Md Nurunnabi5,Marwa A.Sallam6,Jun Wu7,Zhongjian Chen8,Lifang Yin1,Wei He1(Department of Pharmaceutics,China Pharmaceutical University;School of Pharmaceutical Sciences,Sun Yat-sen University,University Town;Jiangsu Aosaikang Pharmaceutical Co.,Ltd.;School of Engineering and Applied Sciences,Harvard University;Department of Pharmaceutical Sciences,School of Pharmacy,University of Texas at El Paso;Department of Industrial Pharmacy,Faculty of Pharmacy,Alexandria University;Department of Geriatric Cardiology,Jiangsu Provincial Key Laboratory of Geriatrics,the First Affiliated Hospital of Nanjing Medical University;Shanghai Skin Disease Hospital,Tongji University School of Medicine).Delivery strategies of amphotericin B for invasive fungal infections[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yanan Li1,Cangang Zhang2,Guo Li3,Guowei Deng4,Hui Zhang1,Yongbing Sun5,Feifei An3(College of Medical Imaging,Shanxi Medical University;Department of Pathogenic Microbiology and Immunology,School of Basic Medical Sciences,Xi'an Jiaotong University;Institute of Medical Engineering,Department of Biophysics,School of Basic Medical Science,Health Science Center,Xi'an Jiaotong University;College of Chemistry and Life Science,Institute of Functional Molecules,Chengdu Normal University;Division of Pharmaceutics,National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine,Jiangxi University of Traditional Chinese Medicine).Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yi Guo1,Hriday Bera1,Changzhi Shi1,Li Zhang1,Dongmei Cun1,Mingshi Yang1,2(Wuya College of Innovation,Shenyang Pharmaceutical University;Department of Pharmacy,Faculty of Health and Medical Sciences,University of Copenhagen).Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Quoc-Viet Le1,Jaiwoo Lee1,Hobin Lee1,Gayong Shim2,Yu-Kyoung Oh1(College of Pharmacy and Research Institute of Pharmaceutical Sciences,Seoul National University;School of Systems Biomedical Science,Soongsil University).Cell membrane-derived vesicles for delivery of therapeutic agents[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Mengsuo Cui1,Hao Pan2,Yupei Su1,Dongyang Fang1,Sen Qiao1,Pingtian Ding1,Weisan Pan1(Department of Pharmaceutics,School of Pharmacy,Shenyang Pharmaceutical University;School of Pharmacy,Liaoning University).Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Junyu Wu,Yang Long,Man Li,Qin He(Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry,Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy Sichuan University).Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition:Interfering with the crosstalk between “seed and soil”[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Rachael V.Dixon1,2,Eldhose Skaria3,Wing Man Lau1,2,Philip Manning2,Mark A.Birch-Machin2,S.Moein Moghimi1,2,Keng Wooi Ng1,2(School of Pharmacy,Faculty of Medical Sciences,Newcastle University;Translational and Clinical Research Institute,Faculty of Medical Sciences,Newcastle University;Wellcome Trust Centre for Cell-Matrix Research,Faculty of Biology,Medicine and Health,University of Manchester).Microneedle-based devices for point-of-care infectious disease diagnostics[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Nicole B.Day,William C.Wixson,C.Wyatt Shields IV(Department of Chemical & Biological Engineering,University of Colorado).Magnetic systems for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Hongwei Chen1,Venkata Chengalvala2,Hongxiang Hu1,Duxin Sun1(Department of Pharmaceutical Sciences,College of Pharmacy,University of Michigan;College of Literature,Science,and the Arts,University of Michigan).Tumor-derived exosomes:Nanovesicles made by cancer cells to promote cancer metastasis[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Yongjiu Lv1,Wei He2,3,Wei Wu1,4,3(Key Laboratory of Smart Drug Delivery of MOE,School of Pharmacy,Fudan University;School of Pharmacy,China Pharmaceutical University;Shanghai Skin Disease Hospital,Tongji University School of Medicine;Center for Medical Research and Innovation,Shanghai Pudong Hospital,Fudan University Pudong Medical Center).Editorial of Special Issue of Hot Topic Reviews in Drug Delivery[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Edgar Pérez-Herrero1,2,3,Alberto Fernández-Medarde4(Departamento de Ingeniería Química y Tecnología Farmacéutica,Universidad de La Laguna;Instituto Universitario de Bio-Orgánica Antonio Gonzalez,Universidad de La Laguna;Instituto Universitario de Tecnologías Biomédicas,Universidad de La Laguna;Instituto de Biología Molecular y Celular Del Cancer,Centro de Investigacion Del Cancer (USAL-CSIC)).The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Editoral Office of Acta Pharmaceutica Sinica(Editoral Office of Acta Pharmaceutica Sinica).Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第8期
  • Maoqi Hou,Rufeng Wang,Shujuan Zhao,Zhengtao Wang(The SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine,The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines,Institute of Chinese Materia Medica,Shanghai University of Traditional Chinese Medicine).Ginsenosides in Panax genus and their biosynthesis[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Ling Yu1,Zhenjie Wang2,Zhuomao Mo1,Binhua Zou3,Yuanyuan Yang3,Rui Sun3,Wen Ma3,Meng Yu3,Shijun Zhang1,Zhiqiang Yu3(Department of Traditional Chinese Medicine,the First Affiliated Hospital,Sun Yat-sen University;The People's Hospital of Gaozhou;School of Pharmaceutical Sciences,Guangdong Provincial Key Laboratory of New Drug Screening,Southern Medical University).Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Chenchen Han1,2,Yifan Li1,Yuwen Zhang1,Yang Wang1,Dongqian Cui1,Tingting Luo1,Yu Zhang1,Qian Liu1,Hao Li1,Chun Wang1,Dexiang Xu2,Yang Ma1,Wei Wei1(Institute of Clinical Pharmacology,Anhui Medical University,Key Laboratory of Anti-Inflammatory and Immune Medicine (Anhui Medical University),Ministry of Education,Anhui Collaborative Innovation Center of Antiinflammatory and Immune Medicine;Public Health and Preventive Medicine Postdoctoral Research Station of Anhui Medical University).Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Anil Ahsan,Mengru Liu,Yanrong Zheng,Wenping Yan,Ling Pan,Yue Li,Shijia Ma,Xingxian Zhang,Ming Cao,Zhanxun Wu,Weiwei Hu,Zhong Chen,Xiangnan Zhang(Institute of Pharmacology & Toxicology,College of Pharmaceutical Sciences,Key Laboratory of Medical Neurobiology of the Ministry of Health of China,Zhejiang University).Natural compounds modulate the autophagy with potential implication of stroke[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Xintong Zhang,Ying Han,Wei Huang,Mingji Jin,Zhonggao Gao(State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Department of Pharmaceutics,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College).The influence of the gut microbiota on the bioavailability of oral drugs[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Chao Li,Tao Sun,Chen Jiang(Key Laboratory of Smart Drug Delivery,Ministry of Education,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Department of Pharmaceutics,School of Pharmacy,Research Center on Aging and Medicine,Fudan University).Recent advances in nanomedicines for the treatment of ischemic stroke[J].Acta Pharmaceutica Sinica B,2021,第7期
  • Lin Hou1,2,Yanlong Liu2,Wei Liu2,Mervat Balash2,Hongling Zhang2,Yi Zhang1,Huijuan Zhang2,Zhenzhong Zhang2(Biotherapy Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou University;School of Pharmacy,School of Pharmaceutical Sciences,Zhengzhou University,Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases).In situ triggering antitumor efficacy of alcoholabuse drug disulfiram through Cu-based metalorganic framework nanoparticles[J].Acta Pharmaceutica Sinica B,2021,第7期
首页 上一页 3 4 5 6 7 下一页 尾页 共有11页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966